Floré Unveils World’s First Line of Probiotics for Neurodiversity
September 19, 2024 09:00 ET
|
Flore
SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Floré, a leader in gut health testing and customized probiotics, has launched its new line of probiotics specifically designed for neurodiversity. The...
2024 Microbiome Market Trends Report: Competitive Environment Analysis, Digital Platform and Marketing Strategies, and AI Adoption in the Industry
August 22, 2024 10:56 ET
|
Research and Markets
Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "2024 Microbiome Market Trend" report has been added to ResearchAndMarkets.com's offering. In the microbiome therapeutics market, some microbiome...
Human Microbiome Market Projected to Surpass to $3 Billion by 2032 with DuPont, Evelo Bio, Finch Therapeutics, Ginkgo Bioworks, Seres Therapeutics, AOBiome, Astarte Medical, Axial Biotherapeutics
August 14, 2024 09:02 ET
|
Research and Markets
Dublin, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Human Microbiome Market Report by Application Disease Product, Countries and Company Analysis, 2024-2032" report has been added to ...
Microbiotica to Present Positive Update on Manufacturing Progress of its Live Biotherapeutic Products for Forthcoming Melanoma and Ulcerative Colitis Clinical Studies
July 09, 2024 04:00 ET
|
Microbiotica
Presentation in Boston at 9th Microbiome Movement Drug Development Summit, 10-12 July 2024 CAMBRIDGE, UK , July 09, 2024 (GLOBE NEWSWIRE) -- Microbiotica, a biopharma company developing a pipeline...
Original Founders of Akkermansia Muciniphila Bring First Gut Health Product to U.S. Consumer Market
June 27, 2024 11:11 ET
|
The Akkermansia Company
The Akkermansia Company, founded by the first scientists to discover and decode Akkermansia muciniphila, announces its launch into the U.S. consumer market